MNMD Mind Medicine (MindMed) Inc
- Stocks
- Healthcare
- NASDAQ: MNMD
Price (delayed)
$11.85
Market cap
$901.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.37
Enterprise value
$909.44M
Relative Growth:
Rel. Growth:
6
Relative Strength:
Rel. Strength:
86
Relative Valuation:
Rel. Valuation:
N/A
Relative Profitability:
Rel. Profitability:
5
Highlights
The company's EPS fell by 44% QoQ but it rose by 39% YoY
The debt has surged by 87% since the previous quarter and by 70% year-on-year
The net income has declined by 48% since the previous quarter and by 12% year-on-year
Key stats
What are the main financial stats of MNMD
Market
Valuations
Earnings
Shares outstanding
76.09M
Market cap
$901.64M
Enterprise value
$909.44M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.83
Price to sales (P/S)
N/A
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$130.32M
Net income
-$114.52M
EBIT
-$110.19M
EBITDA
-$110.19M
Free cash flow
-$101.56M
Per share
Balance sheet
Liquidity
EPS
-$1.37
EPS diluted
-$1.54
Free cash flow per share
-$1.19
Book value per share
$2.45
Revenue per share
$0
TBVPS
$2.87
Total assets
$265.09M
Total liabilities
$79.69M
Debt
$41.19M
Equity
$185.4M
Working capital
$151.18M
Debt to equity
0.22
Current ratio
4.98
Quick ratio
4.82
Net debt/EBITDA
-0.07
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-39.4%
Return on equity
-50.2%
Return on invested capital
-120.4%
Return on capital employed
-48.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MNMD stock price
How has the Mind Medicine (MindMed) stock price performed over time
Intraday
2.78%
1 week
-11.5%
1 month
-3.03%
1 year
75.56%
YTD
70.26%
QTD
0.51%
Financial performance
How have Mind Medicine (MindMed)'s revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$130.32M
Net income
-$114.52M
Gross margin
N/A
Net margin
N/A
The net income has declined by 48% since the previous quarter and by 12% year-on-year
The operating income has declined by 44% year-on-year and by 14% since the previous quarter
Price vs fundamentals
How does MNMD's price correlate with its fundamentals
Growth
What is Mind Medicine (MindMed)'s growth rate over time
Valuation
What is Mind Medicine (MindMed) stock price valuation
P/E
N/A
P/B
4.83
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 44% QoQ but it rose by 39% YoY
The P/B is 124% above the last 4 quarters average of 2.1 and 57% above the 5-year quarterly average of 3.0
Mind Medicine (MindMed)'s equity has decreased by 17% from the previous quarter and by 8% YoY
Efficiency
How efficient is Mind Medicine (MindMed) business performance
The ROE has dropped by 50% since the previous quarter but it is up by 30% year-on-year
MNMD's ROA is down by 48% from the previous quarter but it is up by 22% YoY
Mind Medicine (MindMed)'s ROIC has increased by 44% from the previous quarter
Dividends
What is MNMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MNMD.
Financial health
How did Mind Medicine (MindMed) financials performed over time
The total liabilities has soared by 52% from the previous quarter and by 21% YoY
The company's current ratio fell by 31% QoQ and by 16% YoY
The debt is 78% smaller than the equity
Mind Medicine (MindMed)'s debt to equity has soared by 120% from the previous quarter and by 83% YoY
The debt has surged by 87% since the previous quarter and by 70% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.